drugset / Trial / NCT06591351

Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA

NCT06591351

Phase 3 Recruiting 870 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of clopidogrel and 300 mg loading aspirin administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200 mg cilostazol and 300 mg loading aspirin were assessed through NIHSS, mRS, and possible adverse effects

Timeline

Start
2022-05-01
Primary completion
2024-09-30
Completion
2024-10-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilostazol Small molecule 100 mg
Comparator Clopidogrel Small molecule 75 mg

Indications